The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...

The FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

In a major policy shift, federal health officials anticipate the shots will be made available to adults 65 and older as well ...

Yesterday the Vaccine Integrity Project (VIP), a panel of leading public health and policy experts, published a viewpoint on ...

The Food and Drug Administration is adjusting the standard of evidence needed for shots to be approved by the general public.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

To understand the mechanism of the nasal vaccines, the researchers first injected mice with a traditional mRNA COVID-19 shot, ...